Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease

References

• Tune JD, Goodwill AG, Sassoon DJ, et al. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:1–15. doi:10.1016/j.trsl.2017.01.001.
   PubMed Web of Science ®Google Scholar
• Kazamel M, Stino AM, Smith AG. Metabolic syndrome and peripheral neuropathy. Muscle Nerve. 2021;63(3):285–293. doi:10.1002/mus.27086.
   PubMed Web of Science ®Google Scholar
• Kasper P, Martin A, Lang S, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021; 10(7):921–937. doi:10.1007/s00392-020-01709-7.
   Google Scholar
• Caussy C, Aubin A, Loomba R. The relationship between type 2 diabetes, NAFLD, and cardiovascular risk. Curr Diab Rep. 2021; 21(5):15. doi:10.1007/s11892-021-01383-7.
   PubMed Web of Science ®Google Scholar
• Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, et al. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38(3):e3502.
   PubMed Web of Science ®Google Scholar
• Paquette M, Bernard S, Cariou B, et al. Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia. J Clin Lipidol. 2023; 17(3):376–383. doi:10.1016/j.jacl.2023.03.008.
   PubMed Web of Science ®Google Scholar
• Sykiotis GP, Bohmann D. Stress-activated cap’n’collar transcription factors in aging and human disease. Sci Signal. 2010;93(112):re3. doi:10.1126/scisignal.3112re3.
   PubMed Web of Science ®Google Scholar
• Kang MI, Kobayashi A, Wakabayashi N, et al. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci U S A. 2004; 101(7):2046–2051. doi:10.1073/pnas.0308347100.
   PubMed Web of Science ®Google Scholar
• Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004; 10(11):549–557. doi:10.1016/j.molmed.2004.09.003.
   PubMed Web of Science ®Google Scholar
• McMahon M, Thomas N, Itoh K, et al. Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem. 2004; 279(30):31556–31567. doi:10.1074/jbc.M403061200.
   PubMed Web of Science ®Google Scholar
• Li W, Kong AN. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog. 2009;48(2):91–104. doi:10.1002/mc.20465.
   PubMed Web of Science ®Google Scholar
• Holtzclaw WD, Dinkova-Kostova AT, Talalay P. Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Adv Enzyme Regul. 2004;44(1):335–367. doi:10.1016/j.advenzreg.2003.11.013.
   PubMedGoogle Scholar
• Hu C, Eggler AL, Mesecar AD, et al. Modification of keap1 cysteine residues by sulforaphane. Chem Res Toxicol. 2011; 24(4):515–521. doi:10.1021/tx100389r.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul. 2006;46(1):113–140. doi:10.1016/j.advenzreg.2006.01.007.
   PubMedGoogle Scholar
• Kobayashi A, Kang MI, Watai Y, et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol. 2006; 26(1):221–229. doi:10.1128/MCB.26.1.221-229.2006.
   PubMed Web of Science ®Google Scholar
• Canning P, Sorrell FJ, Bullock AN. Structural basis of Keap1 interactions with Nrf2. Free Radic Biol Med. 2015;88(Pt B):101–107. doi:10.1016/j.freeradbiomed.2015.05.034.
   PubMed Web of Science ®Google Scholar
• Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85(4):241–272. doi:10.1007/s00204-011-0674-5.
   PubMed Web of Science ®Google Scholar
• Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016; 73(17):3221–3247. doi:10.1007/s00018-016-2223-0.
   PubMed Web of Science ®Google Scholar
• Loboda A, Jazwa A, Grochot-Przeczek A, et al. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2008; 10(10):1767–1812. doi:10.1089/ars.2008.2043.
   PubMed Web of Science ®Google Scholar
• Stucki D, Stahl W. Carbon monoxide - beyond toxicity? Toxicol Lett. 2020; 333:251–260. doi:10.1016/j.toxlet.2020.08.010.
   PubMed Web of Science ®Google Scholar
• Sack MN, Fyhrquist FY, Saijonmaa OJ, et al. Basic biology of oxidative stress and the cardiovascular system: part 1 of a 3-Part series. J Am Coll Cardiol. 2017; 70(2):196–211. doi:10.1016/j.jacc.2017.05.034.
   PubMed Web of Science ®Google Scholar
• Munzel T, Camici GG, Maack C, et al. Impact of oxidative stress on the heart and vasculature: part 2 of a 3-Part series. J Am Coll Cardiol. 2017; 70(2):212–229. doi:10.1016/j.jacc.2017.05.035.
   PubMed Web of Science ®Google Scholar
• Yan SH, Zhao NW, Geng ZR, et al. Modulations of Keap1-Nrf2 signaling axis by TIIA ameliorated the oxidative stress-induced myocardial apoptosis. Free Radic Biol Med. 2018; 115:191–201. doi:10.1016/j.freeradbiomed.2017.12.001.
   PubMed Web of Science ®Google Scholar
• Bai Y, Wang X, Zhao S, et al. Sulforaphane protects against cardiovascular disease via Nrf2 activation. Oxid Med Cell Longev. 2015;2015:407580–407513. doi:10.1155/2015/407580.
   PubMed Web of Science ®Google Scholar
• Wu L, Li HH, Wu Q, et al. Lipoxin A4 activates Nrf2 pathway and ameliorates cell damage in cultured cortical astrocytes exposed to oxygen-glucose deprivation/reperfusion insults. J Mol Neurosci. 2015;56(4):848–857. doi:10.1007/s12031-015-0525-6.
   PubMed Web of Science ®Google Scholar
• Chang CL, Au LC, Huang SW, et al. Insulin up-regulates heme oxygenase-1 expression in 3T3-L1 adipocytes via PI3-kinase- and PKC-dependent pathways and heme oxygenase-1-associated microRNA downregulation. Endocrinology. 2011;152(2):384–393. doi:10.1210/en.2010-0493.
   PubMed Web of Science ®Google Scholar
• Geraldes P, Yagi K, Ohshiro Y, et al. Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/akt-2 pathway. J Biol Chem. 2008; 283(49):34327–34336. doi:10.1074/jbc.M807036200.
   PubMed Web of Science ®Google Scholar
• Yu ZW, Li D, Ling WH, et al. Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: a novel opportunity for diabetes treatment? World J Diabetes. 2012;3(1):19–28. 3 doi:10.4239/wjd.v3.i1.19.
   PubMedGoogle Scholar
• Tullet JM, Hertweck M, An JH, et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell. 2008;132(6):1025–1038. doi:10.1016/j.cell.2008.01.030.
   PubMed Web of Science ®Google Scholar
• Kumar A, Katz LS, Schulz AM, et al. Activation of Nrf2 is required for normal and ChREBPalpha-augmented glucose-stimulated beta-cell proliferation. Diabetes. 2018;67(8):1561–1575. doi:10.2337/db17-0943.
   PubMed Web of Science ®Google Scholar
• Baumel-Alterzon S, Katz LS, Brill G, et al. Nrf2: the master and captain of beta cell fate. Trends Endocrinol Metab. 2021; 32(1):7–19. doi:10.1016/j.tem.2020.11.002.
   PubMed Web of Science ®Google Scholar
• Kuosmanen SM, Kansanen E, Kaikkonen MU, et al. NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation. Nucleic Acids Res. 2018; 46(3):1124–1138. doi:10.1093/nar/gkx1155.
   PubMed Web of Science ®Google Scholar
• Ghesquiere B, Wong BW, Kuchnio A, et al. Metabolism of stromal and immune cells in health and disease. Nature. 2014;511(7508):167–176. doi:10.1038/nature13312.
   PubMed Web of Science ®Google Scholar
• Potente M, Makinen T. Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol. 2017;18(8):477–494. doi:10.1038/nrm.2017.36.
   PubMed Web of Science ®Google Scholar
• Bochkov VN, Oskolkova OV, Birukov KG, et al. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal. 2010;12(8):1009–1059. doi:10.1089/ars.2009.2597.
   PubMed Web of Science ®Google Scholar
• Schoors S, De Bock K, Cantelmo AR, et al. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab. 2014; 19(1):37–48. doi:10.1016/j.cmet.2013.11.008.
   PubMed Web of Science ®Google Scholar
• De Bock K, Georgiadou M, Schoors S, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 2013;154(3):651–663. doi:10.1016/j.cell.2013.06.037.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zuo Z, Li L, et al. Nrf2 in adipocytes. Arch Pharm Res. 2020;43(3):350–360. doi:10.1007/s12272-020-01227-0.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tabuchi T, Tamaki Y, et al. Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem Biophys Res Commun. 2009; 382(3):549–554. doi:10.1016/j.bbrc.2009.03.059.
   PubMed Web of Science ®Google Scholar
• Yu Z, Shao W, Chiang Y, et al. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia. 2011;54(4):922–934. doi:10.1007/s00125-010-2001-8.
   PubMed Web of Science ®Google Scholar
• Shin S, Wakabayashi J, Yates MS, et al. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol. 2009; 620(1–3):138–144. doi:10.1016/j.ejphar.2009.08.022.
   PubMed Web of Science ®Google Scholar
• Kitteringham NR, Abdullah A, Walsh J, et al. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. J Proteomics. 2010; 73(8):1612–1631. doi:10.1016/j.jprot.2010.03.018.
   PubMed Web of Science ®Google Scholar
• Jin X, Xu Z, Cao J, et al. HO-1/EBP interaction alleviates cholesterol-induced hypoxia through the activation of the AKT and Nrf2/mTOR pathways and inhibition of carbohydrate metabolism in cardiomyocytes. Int J Mol Med. 2017; 39(6):1409–1420. doi:10.3892/ijmm.2017.2979.
   PubMed Web of Science ®Google Scholar
• Ooi BK, Goh BH, Yap WH. Oxidative stress in cardiovascular diseases: involvement of Nrf2 antioxidant redox signaling in macrophage foam cells formation. Int J Mol Sci. 2017;18(11):2336. doi:10.3390/ijms18112336.
   Web of Science ®Google Scholar
• Alonso-Pineiro JA, Gonzalez-Rovira A, Sanchez-Gomar I, et al. Nrf2 and heme oxygenase-1 involvement in atherosclerosis related oxidative stress. Antioxidants. 2021;10(9):1463. doi:10.3390/antiox10091463.
   Web of Science ®Google Scholar
• Sacerdoti D, Singh SP, Schragenheim J, et al. Development of NASH in obese mice is confounded by adipose tissue increase in inflammatory NOV and oxidative stress. Int J Hepatol. 2018;2018:3484107–3484114. doi:10.1155/2018/3484107.
   PubMed Web of Science ®Google Scholar
• de la Rosa F, De Troch M, Gabriela M, et al. Physiological responses and specific fatty acids composition of Microcystis aeruginosa exposed to total solar radiation and increased temperature. Photochem Photobiol Sci. 2021;20(6):805–821. doi:10.1007/s43630-021-00061-7.
   PubMed Web of Science ®Google Scholar
• Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054–2081. doi:10.1080/15548627.2020.1810918.
   PubMed Web of Science ®Google Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014; 156(1–2):317–331. doi:10.1016/j.cell.2013.12.010.
   PubMed Web of Science ®Google Scholar
• Tang H, Inoki K, Brooks SV, et al. mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism. Aging Cell. 2019;18(3):e12943. doi:10.1111/acel.12943.
   PubMed Web of Science ®Google Scholar
• Wu B, Li J, Ni H, et al. TLR4 activation promotes the progression of experimental autoimmune myocarditis to dilated cardiomyopathy by inducing mitochondrial dynamic imbalance. Oxid Med Cell Longev. 2018;2018:3181278–3181215. doi:10.1155/2018/3181278.
   PubMed Web of Science ®Google Scholar
• Yao X, Carlson D, Sun Y, et al. Mitochondrial ROS induces cardiac inflammation via a pathway through mtDNA damage in a pneumonia-related sepsis model. PLOS One. 2015;10(10):e0139416. doi:10.1371/journal.pone.0139416.
   PubMed Web of Science ®Google Scholar
• Tsushima M, Liu J, Hirao W, et al. Emerging evidence for crosstalk between Nrf2 and mitochondria in physiological homeostasis and in heart disease. Arch Pharm Res. 2020; 43(3):286–296. doi:10.1007/s12272-019-01188-z.
   PubMed Web of Science ®Google Scholar
• Khan AUH, Allende-Vega N, Gitenay D, et al. Mitochondrial complex I activity signals antioxidant response through ERK5. Sci Rep. 2018; 8(1):7420. doi:10.1038/s41598-018-23884-4.
   PubMedGoogle Scholar
• Itoh K, Ye P, Matsumiya T, et al. Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria. J Clin Biochem Nutr. 2015;56(2):91–97. doi:10.3164/jcbn.14-134.
   PubMed Web of Science ®Google Scholar
• Murata H, Takamatsu H, Liu S, et al. NRF2 regulates PINK1 expression under oxidative stress conditions. PLOS One. 2015;10(11):e0142438. doi:10.1371/journal.pone.0142438.
   PubMed Web of Science ®Google Scholar
• Morais VA, Haddad D, Craessaerts K, et al. PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling. Science. 2014;344(6180):203–207. doi:10.1126/science.1249161.
   PubMed Web of Science ®Google Scholar
• Wu Z, Sawada T, Shiba K, et al. Tricornered/NDR kinase signaling mediates PINK1-directed mitochondrial quality control and tissue maintenance. Genes Dev. 2013;27(2):157–162. doi:10.1101/gad.203406.112.
   PubMed Web of Science ®Google Scholar
• Tomlin FM, Gerling-Driessen UIM, Liu YC, et al. Inhibition of NGLY1 inactivates the transcription factor Nrf1 and potentiates proteasome inhibitor cytotoxicity. ACS Cent Sci. 2017;3(11):1143–1155. doi:10.1021/acscentsci.7b00224.
   PubMed Web of Science ®Google Scholar
• Berthiaume JM, Kurdys JG, Muntean DM, et al. Mitochondrial NAD(+)/NADH redox state and diabetic cardiomyopathy. Antioxid Redox Signal. 2019; 30(3):375–398. doi:10.1089/ars.2017.7415.
   PubMed Web of Science ®Google Scholar
• Strom J, Xu B, Tian X, et al. Nrf2 protects mitochondrial decay by oxidative stress. Faseb J. 2016;30(1):66–80. doi:10.1096/fj.14-268904.
   PubMed Web of Science ®Google Scholar
• Lee SC, Zhang J, Strom J, et al. G-Quadruplex in the NRF2 mRNA 5’ untranslated region regulates De novo NRF2 protein translation under oxidative stress. Mol Cell Biol. 2017;37(1)e00122-16. doi:10.1128/MCB.00122-16.
   Web of Science ®Google Scholar
• Ago T, Kuroda J, Pain J, et al. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010; 106(7):1253–1264. doi:10.1161/CIRCRESAHA.109.213116.
   PubMed Web of Science ®Google Scholar
• Block K, Gorin Y, Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A. 2009106(34):14385–14390. doi:10.1073/pnas.0906805106.
   PubMed Web of Science ®Google Scholar
• Kasai S, Yamazaki H, Tanji K, et al. Role of the ISR-ATF4 pathway and its cross talk with Nrf2 in mitochondrial quality control. J Clin Biochem Nutr. 2019; 64(1):1–12. doi:10.3164/jcbn.18-37.
   PubMed Web of Science ®Google Scholar
• O’Mealey GB, Plafker KS, Berry WL, et al. A PGA. M5KEAP1-Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking. J Cell Sci. 2017; 130(20):3467–3480.
   PubMed Web of Science ®Google Scholar
• Taha H, Skrzypek K, Guevara I, et al. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol. 201030(8):1634–1641. doi:10.1161/ATVBAHA.110.207316.
   PubMed Web of Science ®Google Scholar
• Mimura J, Itoh K. Role of Nrf2 in the pathogenesis of atherosclerosis. Free Radic Biol Med. 2015;88(Pt B):221–232. doi:10.1016/j.freeradbiomed.2015.06.019.
   PubMedGoogle Scholar
• Orozco LD, Kapturczak MH, Barajas B, et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res. 2007; 100(12):1703–1711. doi:10.1161/CIRCRESAHA.107.151720.
   PubMed Web of Science ®Google Scholar
• Ziberna L, Martelanc M, Franko M, et al. Bilirubin is an endogenous antioxidant in human vascular endothelial cells. Sci Rep. 2016; 6(1):29240. doi:10.1038/srep29240.
   PubMedGoogle Scholar
• Kwon YJ, Lee HS, Lee JW. Direct bilirubin is associated with low-density lipoprotein subfractions and particle size in overweight and centrally obese women. Nutr Metab Cardiovasc Dis. 2018;28(10):1021–1028. doi:10.1016/j.numecd.2018.05.013.
   PubMed Web of Science ®Google Scholar
• Loboda A, Jozkowicz A, Dulak J. HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy. Vascul Pharmacol. 2015;74:11–22. doi:10.1016/j.vph.2015.09.004.
   PubMed Web of Science ®Google Scholar
• Dragoni S, Turowski P. Polarised VEGFA signalling at vascular blood-neural barriers. Int J Mol Sci. 2018;19(5):1378. doi:10.3390/ijms19051378.
   PubMed Web of Science ®Google Scholar
• Kang IS, Kim RI, Kim C. Carbon monoxide regulates macrophage differentiation and polarization toward the M2 phenotype through upregulation of heme oxygenase 1. Cells. 2021; 10(12):3444. doi:10.3390/cells10123444.
   PubMed Web of Science ®Google Scholar
• Leake A, Salem K, Madigan MC, et al. Systemic vasoprotection by inhaled carbon monoxide is mediated through prolonged alterations in monocyte/macrophage function. Nitric Oxide. 2020;94:36–47. doi:10.1016/j.niox.2019.10.003.
   PubMed Web of Science ®Google Scholar
• Bilban M, Haschemi A, Wegiel B, et al. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med . 2008;86(3):267–279. doi:10.1007/s00109-007-0276-0.
   PubMed Web of Science ®Google Scholar
• Magierowski M, Magierowska K, Hubalewska-Mazgaj M, et al. Cross-talk between hydrogen sulfide and carbon monoxide in the mechanism of experimental gastric ulcers healing, regulation of gastric blood flow and accompanying inflammation. Biochem Pharmacol. 2018; 149:131–142. doi:10.1016/j.bcp.2017.11.020.
   PubMed Web of Science ®Google Scholar
• Hartsfield CL. Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal. 2002;4(2):301–307. doi:10.1089/152308602753666352.
   PubMed Web of Science ®Google Scholar
• Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med. 2003; 9(2):183–190. doi:10.1038/nm817.
   PubMed Web of Science ®Google Scholar
• Huang J, Tabbi-Anneni I, Gunda V, et al. Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am J Physiol Gastrointest Liver Physiol. 2010;299(6):G1211–21. doi:10.1152/ajpgi.00322.2010.
   PubMed Web of Science ®Google Scholar
• Barajas B, Che N, Yin F, et al. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arterioscler Thromb Vasc Biol. 2011;31(1):58–66. doi:10.1161/ATVBAHA.110.210906.
   PubMed Web of Science ®Google Scholar
• Freigang S, Ampenberger F, Spohn G, et al. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol. 2011;41(7):2040–2051. doi:10.1002/eji.201041316.
   PubMed Web of Science ®Google Scholar
• Ishii T, Itoh K, Ruiz E, et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res. 2004;94(5):609–616. doi:10.1161/01.RES.0000119171.44657.45.
   PubMed Web of Science ®Google Scholar
• Kadl A, Meher AK, Sharma PR, et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res. 2010; 107(6):737–746. doi:10.1161/CIRCRESAHA.109.215715.
   PubMed Web of Science ®Google Scholar
• Boyle JJ, Johns M, Kampfer T, et al. Activating transcription factor 1 directs mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ Res. 2012; 110(1):20–33. doi:10.1161/CIRCRESAHA.111.247577.
   PubMed Web of Science ®Google Scholar
• Boyle JJ, Johns M, Lo J, et al. Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2011; 31(11):2685–2691. doi:10.1161/ATVBAHA.111.225813.
   PubMed Web of Science ®Google Scholar
• Small HY, Migliarino S, Czesnikiewicz-Guzik M, et al. Hypertension: focus on autoimmunity and oxidative stress. Free Radic Biol Med. 2018; 125:104–115. doi:10.1016/j.freeradbiomed.2018.05.085.
   PubMed Web of Science ®Google Scholar
• Chen Q, Wang Q, Zhu J, et al. Reactive oxygen species: key regulators in vascular health and diseases. Br J Pharmacol. 2018; 175(8):1279–1292. doi:10.1111/bph.13828.
   PubMed Web of Science ®Google Scholar
• Li H, Horke S, Forstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014; 237(1):208–219. doi:10.1016/j.atherosclerosis.2014.09.001.
   PubMed Web of Science ®Google Scholar
• Luo Z, Aslam S, Welch WJ, et al. Activation of nuclear factor erythroid 2-related factor 2 coordinates dimethylarginine dimethylaminohydrolase/PPAR-gamma/endothelial nitric oxide synthase pathways that enhance nitric oxide generation in human glomerular endothelial cells. Hypertension. 2015;65(4):896–902. doi:10.1161/HYPERTENSIONAHA.114.04760.
   PubMed Web of Science ®Google Scholar
• Lopes RA, Neves KB, Tostes RC, et al. Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension. Hypertension. 2015; 66(6):1240–1250. doi:10.1161/HYPERTENSIONAHA.115.06163.
   PubMed Web of Science ®Google Scholar
• Neves KB, Rios FJ, van der Mey L, et al. VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes. Hypertension. 2018;71(4):638–647. doi:10.1161/HYPERTENSIONAHA.117.10490.
   PubMed Web of Science ®Google Scholar
• Cuevas S, Yang Y, Konkalmatt P, et al. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1. Hypertension. 2015;65(6):1251–1257. doi:10.1161/HYPERTENSIONAHA.114.04525.
   PubMed Web of Science ®Google Scholar
• Shirakawa, H, Giriwono, P. E, Oguchi, K, et al. Fermented barley extract supplementation ameliorates metabolic state in stroke-prone spontaneously hypertensive rats. Biosci Biotechnol Biochem. 2015;79(11):1876–1883. doi:10.1080/09168451.2015.1052772.
   PubMed Web of Science ®Google Scholar
• Manzanero S, Santro T, Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int. 2013; 62(5):712–718. doi:10.1016/j.neuint.2012.11.009.
   PubMed Web of Science ®Google Scholar
• Taylor JM, Crack PJ. Impact of oxidative stress on neuronal survival. Clin Exp Pharmacol Physiol. 2004; 31(7):397–406. doi:10.1111/j.1440-1681.2004.04017.x.
   PubMed Web of Science ®Google Scholar
• de Groot H, Rauen U. Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplant Proc. 2007; 39(2):481–484. doi:10.1016/j.transproceed.2006.12.012.
   PubMed Web of Science ®Google Scholar
• Marzocca C, Vannacci A, Cuzzocrea S, et al. Effects of the SOD mimetic, M40403, on prostaglandin production in an in vivo model of ischemia and reperfusion in rat heart. Inflamm Res. 2003;52 Suppl 1:S23–S4. doi:10.1007/s000110300037.
   PubMed Web of Science ®Google Scholar
• Cadenas E, Boveris A, Ragan CI, et al. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys. 1977; 180(2):248–257. doi:10.1016/0003-9861(77)90035-2.
   PubMed Web of Science ®Google Scholar
• Galang N, Sasaki H, Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. Toxicology. 2000; 148(2–3):111–118. doi:10.1016/s0300-483x(00)00201-8.
   PubMed Web of Science ®Google Scholar
• Cominacini L, Mozzini C, Garbin U, et al. Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases. Free Radic Biol Med. 2015;88(Pt B):233–242. doi:10.1016/j.freeradbiomed.2015.05.027.
   PubMedGoogle Scholar
• Gurusamy N, Malik G, Gorbunov NV, et al. Redox activation of ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radic Biol Med. 2007;43(3):397–407. doi:10.1016/j.freeradbiomed.2007.04.025.
   PubMed Web of Science ®Google Scholar
• Yang J, Yin HS, Cao YJ, et al. Arctigenin attenuates ischemia/reperfusion induced ventricular arrhythmias by decreasing oxidative stress in rats. Cell Physiol Biochem. 2018;49(2):728–742. doi:10.1159/000493038.
   PubMedGoogle Scholar
• Li H, Yao W, Irwin MG, et al. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Free Radic Biol Med. 2015; 84:311–321. doi:10.1016/j.freeradbiomed.2015.03.007.
   PubMed Web of Science ®Google Scholar
• Gao X, Xu Y, Xu B, et al. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes. Diabetes Metab Res Rev. 2012;28(5):409–417. doi:10.1002/dmrr.2295.
   PubMed Web of Science ®Google Scholar
• Tan Y, Ichikawa T, Li J, et al. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 2011;60(2):625–633. doi:10.2337/db10-1164.
   PubMed Web of Science ®Google Scholar
• Li B, Liu S, Miao L, et al. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Exp Diabetes Res. 2012;2012:216512–216517. doi:10.1155/2012/216512.
   PubMedGoogle Scholar
• Hu CM, Chen YH, Chiang MT, et al. Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation. 2004; 110(3):309–316. doi:10.1161/01.CIR.0000135475.35758.23.
   PubMed Web of Science ®Google Scholar
• Chen XJ, Ren SM, Dong JZ, et al. Ginkgo biloba extract-761 protects myocardium by regulating akt/Nrf2 signal pathway. Drug Des Devel Ther. 2019;13:647–655. doi:10.2147/DDDT.S191537.
   PubMed Web of Science ®Google Scholar
• Lian Y, Xia X, Zhao H, et al. The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice. Biomed Pharmacother. 2017;Sep93:1175–1189. doi:10.1016/j.biopha.2017.05.148.
   PubMed Web of Science ®Google Scholar
• Li S, Wang W, Niu T, et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Longev. 2014;2014:748524–748515. doi:10.1155/2014/748524.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee IK, Jeon JH. Vascular calcification-new insights into its mechanism. Int J Mol Sci. 2020;21(8):2685. doi:10.3390/ijms21082685.
   Web of Science ®Google Scholar
• Yuan C, Ni L, Zhang C, et al. Vascular calcification: new insights into endothelial cells. Microvasc Res. 2021;134:104105. doi:10.1016/j.mvr.2020.104105.
   PubMed Web of Science ®Google Scholar
• Wei R, Enaka M, Muragaki Y. Activation of KEAP1/NRF2/P6 signaling alleviates high phosphate-induced calcification of vascular smooth muscle cells by suppressing reactive oxygen species production. Sci Rep. 2019; 79(1):10366. doi:10.1038/s41598-019-46824-2.
   PubMedGoogle Scholar
• Ji R, Sun H, Peng J, et al. Rosmarinic acid exerts an antagonistic effect on vascular calcification by regulating the Nrf2 signalling pathway. Free Radic Res. 2019; 53(2):187–197. doi:10.1080/10715762.2018.1558447.
   PubMed Web of Science ®Google Scholar
• Bletsa E, Paschou SA, Tsigkou V, et al. The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review. Hormones. 2022;21(4):599–610. doi:10.1007/s42000-022-00403-9.
   PubMedGoogle Scholar
• Mori H, Torii S, Kutyna M, et al. Coronary artery calcification and its progression: what does it really mean? JACC Cardiovasc Imaging. 2018; 11(1):127–142. doi:10.1016/j.jcmg.2017.10.012.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Fergestrom N, Gage BF, et al. Impact of statins on cardiovascular outcomes following coronary artery calcium scoring. J Am Coll Cardiol. 2018; 72(25):3233–3242. doi:10.1016/j.jacc.2018.09.051.
   PubMed Web of Science ®Google Scholar